Want to see TSE:CDVA full AI Analyst Report?
CDVA Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.08
Previous CloseN/A
Volume0.00
Average Volume (3M)44.87K
Market Cap
C$4.39M
Enterprise ValueC$10.15M
Total Cash (Recent Filing)C$515.15K
Total Debt (Recent Filing)C$5.17M
Price to Earnings (P/E)―
Beta4.42
Next Earnings
Nov 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding109,803,460
10 Day Avg. Volume14,141
30 Day Avg. Volume44,872
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-1.04
Price to Sales (P/S)0.42
P/FCF Ratio5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Recovery (EBIT Turned Positive)EBIT moving to positive on a TTM basis indicates the company has started to convert revenue into operating profits, reflecting sustainable cost control or mix improvement. That structural operating improvement reduces burn, supports internal funding, and lessens reliance on external capital over months.
Positive Operating And Free Cash FlowConsistent positive operating and free cash flow, even if modest, is a durable sign the core business can generate liquidity. Over 2–6 months this improves funding optionality, lowers immediate refinancing pressure, and enables incremental reinvestment or targeted deleveraging if maintained.
Lean Operating Scale And Niche Industry PositioningA small employee base and focus in specialty/generic drug manufacturing imply a lean cost structure and niche operational focus. This structural setup can sustain margin improvement and agility, allowing management to prioritize high-return projects and adapt to regulatory or commercial shifts over the medium term.
Bears Say
Negative Shareholders' EquityPersistent negative equity signals cumulative losses and an impaired capital base, constraining financial flexibility. Over months this elevates refinancing and dilution risk, complicates raising debt or equity on favorable terms, and can limit strategic options if not remedied by sustained profits or capital injections.
Meaningful Debt Vs Impaired EquityMaterial debt against an impaired equity base increases leverage risk and reduces resilience to cashflow shocks. With modest free cash flow, servicing or refinancing that debt could divert capital from growth or force dilutive financings, making capital structure repair a durable constraint on strategy execution.
Weak Margins And Continued LossesLow gross margins and a persistent net loss indicate structural profitability challenges in converting sales to sustainable earnings. Even with operating improvement, negative margins and steep EPS contraction imply the company must materially grow revenue or improve mix to self-fund growth and de-lever over the medium term.
CordovaCann News
CDVA FAQ
What was CordovaCann Corp.’s price range in the past 12 months?
CordovaCann Corp. lowest stock price was <C$0.01 and its highest was C$0.08 in the past 12 months.
What is CordovaCann Corp.’s market cap?
CordovaCann Corp.’s market cap is C$4.39M.
When is CordovaCann Corp.’s upcoming earnings report date?
CordovaCann Corp.’s upcoming earnings report date is Nov 02, 2026 which is in 123 days.
How were CordovaCann Corp.’s earnings last quarter?
CordovaCann Corp. released its earnings results on May 28, 2026. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is CordovaCann Corp. overvalued?
According to Wall Street analysts CordovaCann Corp.’s price is currently Overvalued.
Does CordovaCann Corp. pay dividends?
CordovaCann Corp. does not currently pay dividends.
What is CordovaCann Corp.’s EPS estimate?
CordovaCann Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CordovaCann Corp. have?
CordovaCann Corp. has 109,803,460 shares outstanding.
What happened to CordovaCann Corp.’s price movement after its last earnings report?
CordovaCann Corp. reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CordovaCann Corp.?
Currently, no hedge funds are holding shares in TSE:CDVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CordovaCann Corp.
CordovaCann Corp. is a company that focuses on various aspects of the cannabis industry, including identifying prospects, securing financing, developing new ventures, and managing operations throughout the entire cannabis value chain. As of February 14, 2022, it oversaw 14 retail outlets operating under the Star Buds Cannabis Co. brand. These stores are located in the Canadian provinces of Ontario, Manitoba, Alberta, and British Columbia, as well as the U.S. states of Oregon and Washington. The company, whose previous name was LiveReel Media Corporation, officially changed to CordovaCann Corp. in January 2018. Its corporate headquarters are situated in Toronto, Canada.